Literature DB >> 9674160

Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.

W P Charteris1, P M Kelly, L Morelli, J K Collins.   

Abstract

Sixteen Bifidobacterium isolates from the human gastrointestinal tract were assayed for susceptibility to 44 antibiotics by soft agar overlay disc diffusion on TPY agar. Five isolates (3/7 B. bifidum and 2/3 B. breve) exhibited atypical antibiotic susceptibility profiles. Poor growth in the agar overlay accounted for susceptibility of B. bifidum but not B. breve isolates. All other isolates were resistant to cefoxitin (30 micrograms), aztreonam (30 micrograms), vancomycin (30 micrograms), amikacin (30 micrograms), gentamicin (10 micrograms), kanamycin (30 micrograms), streptomycin (10 micrograms), fusidic acid (10 micrograms), trimethoprim (5 micrograms), norfloxacin (10 micrograms), nalidixic acid (30 micrograms), metronidazole (5 micrograms), polymyxin B (300 micrograms) and colistin sulphate (10 micrograms), and they were susceptible to the six penicillins studied, cephalothin (30 micrograms), cefuroxime (30 micrograms), cefaclor (30 micrograms), ceftizoxime (30 micrograms), cefotaxime (30 micrograms), bacitracin (10 micrograms), chloramphenicol (30 micrograms), erythromycin (15 micrograms), clindamycin (2 micrograms), rifampicin (5 micrograms) and nitrofurantoin (300 micrograms). In addition, they varied in their susceptibility to cephradine (30 micrograms), cephazolin (30 micrograms), cefoperazone (75 micrograms), ceftriaxone (30 micrograms), ofloxacin (5 micrograms) and furazolidone (15 micrograms). They were resistant, or only marginally moderately susceptible, to ceftazidime (30 micrograms), netilmicin (10 micrograms), sulphamethoxazole (100 micrograms), cotrimoxazole (25 micrograms) and ciprofloxacin (5 micrograms), and susceptible or marginally moderately susceptible to tetracycline (30 micrograms). All B. bifidum isolates were susceptible to cefixime (5 micrograms). Four microorganism-drug combinations were evaluated for beta-lactamase activity but its absence suggested that cell wall impermeability was responsible for cephalosporin resistance among bifidobacteria. The antibiotic susceptibility of B. animalis 25527T was similar to that of the human isolates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674160     DOI: 10.1046/j.1472-765x.1998.00342.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  14 in total

1.  Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.

Authors:  Fausta Serafini; Francesca Bottacini; Alice Viappiani; Enrico Baruffini; Francesca Turroni; Elena Foroni; Tiziana Lodi; Douwe van Sinderen; Marco Ventura
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

2.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

3.  Macrolide resistance mediated by a Bifidobacterium breve membrane protein.

Authors:  Abelardo Margolles; José Antonio Moreno; Douwe van Sinderen; Clara G de Los Reyes-Gavilán
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.

Authors:  Eirin Esaiassen; Erik Hjerde; Jorunn Pauline Cavanagh; Gunnar Skov Simonsen; Claus Klingenberg
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

5.  Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

Authors:  Susana Delgado; Ana Belén Flórez; Baltasar Mayo
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

6.  Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products.

Authors:  Muhammad Nawaz; Juan Wang; Aiping Zhou; Chaofeng Ma; Xiaokang Wu; John E Moore; B Cherie Millar; Jiru Xu
Journal:  Curr Microbiol       Date:  2011-01-07       Impact factor: 2.188

Review 7.  Accessing the inaccessible: molecular tools for bifidobacteria.

Authors:  Zhongke Sun; Annika Baur; Daria Zhurina; Jing Yuan; Christian U Riedel
Journal:  Appl Environ Microbiol       Date:  2012-05-11       Impact factor: 4.792

8.  Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).

Authors:  Geert Huys; Nadine Botteldoorn; Frank Delvigne; Luc De Vuyst; Marc Heyndrickx; Bruno Pot; Jean-Jacques Dubois; Georges Daube
Journal:  Mol Nutr Food Res       Date:  2013-06-25       Impact factor: 5.914

9.  Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance.

Authors:  Min Zheng; Ruijia Zhang; Xuechen Tian; Xuan Zhou; Xutong Pan; Aloysius Wong
Journal:  Front Microbiol       Date:  2017-05-19       Impact factor: 5.640

10.  Characterization of Selected Lactobacillus Strains for Use as Probiotics.

Authors:  Minyu Song; Bohyun Yun; Jae-Hak Moon; Dong-June Park; Kwangsei Lim; Sejong Oh
Journal:  Korean J Food Sci Anim Resour       Date:  2015-08-31       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.